Phytochemical Profiling, In Vivo Evaluation, and In Silico Insights Into the Antihyperlipidemic Potential of Thymus linearis Extract
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202501986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Sumaira Saleem und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Institute of Chemical Sciences, Government College University Lahore, Lahore, Pakistan. Hauptthemen laut MEDLINE: Hypolipidemic Agents, Phytochemicals, Plant Extracts, Hyperlipidemias. Die Arbeit nennt 91 Literaturangaben.
Abstract (Originalsprache)
Hyperlipidemia, a major risk factor for ischemic heart disease, is commonly managed with statins, which, despite their efficacy, are associated with adverse effects such as myopathy. This study evaluated the antihyperlipidemic potential of Thymus linearis extract (250 and 500 mg/kg body weight) in Swiss albino mice (six groups, n = 5) fed a high‐cholesterol diet. Biological parameters, including body weight, glycemic indices, lipid profile, biochemical markers, and histopathological changes in the liver and kidney, were assessed. Phytochemical profiling using GC–MS revealed the presence of 12 bioactive compounds. Molecular docking confirmed the strong binding affinities of the metabolites to key targets, including the peroxisome proliferator‐activated receptor (PPAR‐α), HMG‐CoA reductase, and acyl‐CoA:cholesterol acyltransferase (ACAT). Density functional theory (DFT) calculations further supported the docking results. MM/GBSA analysis showed that compounds 1 , 11 , and 12 exhibited binding energies of −73.13, −52.51, and −13.83 kcal/mol, respectively. ADMET studies indicated that, except for compounds 5 , 10 , and 12 , all compounds complied with Lipinski's rule of five. Histological analyses revealed reduced adipocyte and hepatocyte sizes, indicating suppressed adipogenesis and improved hepatic architecture. In conclusion, the extract at 500 mg/kg improved lipid profiles and enhanced insulin sensitivity, comparable to simvastatin (1.5 mg/kg).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Institute of Chemical Sciences, Government College University Lahore, Lahore, Pakistan.
- Department of Chemistry and Chemical Engineering, Syed Babar Ali School of Science & Engineering (SBASSE), Lahore University of Management Sciences (LUMS), Lahore, Pakistan.
- Gulab Devi Institute of Pharmacy, Gulab Devi Educational Complex, Lahore, Pakistan.
- Department of Pharmaceutical Sciences, Government College University Lahore, Lahore, Pakistan.
- Institute of Pharmaceutical Sciences, University of Veterinary and Animal Science, Lahore, Pakistan.
ORCID-Profile: Gulzar Muhammad
Zitieren
APA
Saleem, S., Naseer, M., Arif, N., Wajid, M., Muhammad, G., Mushtaq, A., Raza, M. A., Adeel, M., & Majeed, A. (2026). Phytochemical Profiling, In Vivo Evaluation, and In Silico Insights Into the Antihyperlipidemic Potential of Thymus linearis Extract. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501986
Vancouver
Saleem S, Naseer M, Arif N, Wajid M, Muhammad G, Mushtaq A, et al. Phytochemical Profiling, In Vivo Evaluation, and In Silico Insights Into the Antihyperlipidemic Potential of Thymus linearis Extract. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202501986
BibTeX
@article{Saleem2026,
author = {Saleem, Sumaira and Naseer, Maryam and Arif, Nimra and Wajid, Muhammad and Muhammad, Gulzar and Mushtaq, Aamir and Raza, Muhammad Arshad and Adeel, Muhammad and Majeed, Aamna},
title = {Phytochemical Profiling, In Vivo Evaluation, and In Silico Insights Into the Antihyperlipidemic Potential of Thymus linearis Extract},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202501986}
}
EUVIMED